Login to Your Account

MGI, SuperGen Get Dacogen Approvable Letter, Have Hope

By Aaron Lorenzo

Tuesday, September 6, 2005
The FDA issued an approvable letter for Dacogen (decitabine) injection, a treatment for myelodysplastic syndromes (MDS) that is partnered between MGI Pharma Inc. and SuperGen Inc., but a request for more material put a slight dent in shares of both companies. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription